Beyond kratom: Concentrated 7-hydroxymitragynine and mitragynine pseudoindoxyl products, an MME potency assessment

Jonathan Heywood, Helen Farnham, Elizabeth Jackson, Katie Steimel, Sarah Brown, Alexander Riordan

Open source

DOI
10.1016/j.yrtph.2026.106272
Published
2027-01
Container
Regulatory Toxicology and Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yrtph.2026.106272,
  title = {Beyond kratom: Concentrated 7-hydroxymitragynine and mitragynine pseudoindoxyl products, an MME potency assessment},
  author = {Jonathan Heywood and Helen Farnham and Elizabeth Jackson and Katie Steimel and Sarah Brown and Alexander Riordan},
  year = {2027},
  journal = {Regulatory Toxicology and Pharmacology},
  doi = {10.1016/j.yrtph.2026.106272},
  url = {https://doi.org/10.1016/j.yrtph.2026.106272}
}

RIS

TY  - JOUR
TI  - Beyond kratom: Concentrated 7-hydroxymitragynine and mitragynine pseudoindoxyl products, an MME potency assessment
AU  - Jonathan Heywood
AU  - Helen Farnham
AU  - Elizabeth Jackson
AU  - Katie Steimel
AU  - Sarah Brown
AU  - Alexander Riordan
PY  - 2027
JO  - Regulatory Toxicology and Pharmacology
DO  - 10.1016/j.yrtph.2026.106272
UR  - https://doi.org/10.1016/j.yrtph.2026.106272
ER  - 

APA

Heywood, J., Farnham, H., Jackson, E., Steimel, K., Brown, S., & Riordan, A. (2027). Beyond kratom: Concentrated 7-hydroxymitragynine and mitragynine pseudoindoxyl products, an MME potency assessment. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2026.106272

Source records